Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 336

Results For "pharma"

3982 News Found

AbbVie and Gedeon Richter to collaborate on neuropsychiatric diseases
Biotech | March 11, 2022

AbbVie and Gedeon Richter to collaborate on neuropsychiatric diseases

Agreement builds on 15 years of successful collaboration between AbbVie and Richter, including globally launched cariprazine products


Emmes acquires Casimir, its fourth major acquisition
Biotech | March 11, 2022

Emmes acquires Casimir, its fourth major acquisition

Casimir further differentiates Emmes’ industry-leading rare disease research capabilities


First-in-human trial in US for Gan & Lee type 2 diabetes drug
Biotech | March 11, 2022

First-in-human trial in US for Gan & Lee type 2 diabetes drug

The primary objective of this Phase 1 study is to investigate the safety and tolerability of GZR18 in healthy volunteers


Strides receives USFDA approval for Colchicine tablets
Drug Approval | March 11, 2022

Strides receives USFDA approval for Colchicine tablets

Colchicine tablets are used for the treatment and prevention of gout. It reduces inflammation which causes pain, swelling and other symptoms of gout


USFDA approves Lupin’s Vigabatrin oral solution
Drug Approval | March 11, 2022

USFDA approves Lupin’s Vigabatrin oral solution

The product will be manufactured at Lupin’s facility in Goa, India


Gujarat Biotech policy offers incentives to attract small and large firms
News | March 10, 2022

Gujarat Biotech policy offers incentives to attract small and large firms

The Gujarat Biotechnology policy released last month has made radical changes to position the state as a biotechnology hub. It already has a thriving ecosystem of pharma companies and varied suppliers


Molecular Health and researchers prove new approach to anticipate molecular causation
Biotech | March 10, 2022

Molecular Health and researchers prove new approach to anticipate molecular causation

The studies demonstrate a standardized strategy to extend mechanistic modeling and systems pharmacology into drug safety and mode of action assessments that has relevance for drug development and a variety of other contexts


Medical devices production under PLI scheme gets off the ground
News | March 10, 2022

Medical devices production under PLI scheme gets off the ground

A total of 21 applicants have been approved for 49 products, with the potential to utilize an incentive amount of Rs. 2541 crore


Gufic Biosciences collaborates with Selvax for cancer treatment
Biotech | March 10, 2022

Gufic Biosciences collaborates with Selvax for cancer treatment

Selvax's goal is to develop safe, effective and immunological-based treatments for a range of hard-to-treat solid tumours


Pfizer initiates Phase2/3 study of Paxlovid in pediatric participants
Biotech | March 10, 2022

Pfizer initiates Phase2/3 study of Paxlovid in pediatric participants

Paxlovid is the first oral therapy specifically designed to combat Covid-19 to be evaluated in a pediatric clinical study